A pilot study is underway to see how mobile technology can be used to improve diabetes care in adults with Type 1 diabetes. The REMOTE-T1D (NCT01825382) study is sponsored by the University of Colorado, Denver School of Medicine in the Barbara Davis Center along with collaborators Sanofi, and the Colorado Prevention Center.
The Principal Investigator Satish K. Garg MD reports that the goal is to evaluate the use of remote technology such as iBGStar in combination with Diabetes Manager App on the iPhone in terms of patient related outcomes and satisfaction with the treatment. There may be possible reductions of glucose excursions, A1C, and severe hypoglycemia as compared to routine clinical care using the traditional glucose meter SMBG-Accu-chek. The study aims to demonstrate the efficacy of these technologies in a clinical setting with the hope to improve outcomes and achieve healthcare cost savings.
In the future, this study might lead to investigating the role of social media used with mobile phones for Type 1 Diabetes care. As the number of patients with Type1Diabetes continues to increase, the use of this technology could possibly help compensate for the shortage of endocrinologists available to provide care.
The study started December 2012 and the completion date is scheduled to be November 2013. The study enrolled 100 patients from the Barbara Davis Center Adult Clinic over the age of 18, and the study will be randomized to an intervention group using mobile technology (iBGStar) versus continued routine clinical care using SMBG-Acc-chek meter. Subjects will be followed frequently and will wear a continuous glucose monitor using a DexCom SEVEN Plus system for 7 days.
For more information, go to http://clinicaltrials.gov/ct2/show/NCT01825382.